ACMG-Bericht
Dieses Produkt ist nur für Kunden gedacht, die bereits
einen MyGenome-Test erworben haben.
Das Dante Labs 59 Gene Actionable Disorders Panel analysiert die 59 Gene, die vom American College of Medical Genetics and Genomics (ACMG; Kalia et al., 2017) als medizinisch aktivierbar eingestuft wurden.
Diese Gene sind medizinisch verwertbar, wobei für die damit verbundenen Erkrankungen klinische Behandlungsrichtlinien festgelegt wurden.
Liste der untersuchten Krankheiten:
- Familiäre adenomatöse Polyposis (FAP)
- Hereditärer Brust- und Eierstockkrebs (HBOC)
- Li-Fraumeni-Syndrom (LFS)
- Peutz-Jeghers-Syndrom (PJS)
- Lynch-Syndrom - auch bekannt als hereditäres nicht-polypöses kolorektales Karzinom (HNPCC)
- MUTYH-assoziierte Polyposis (MAP)
- Von-Hippel-Lindau-Syndrom (VHL)
- Multiple endokrine Neoplasie Typ 1 (MEN1)
- Multiple endokrine Neoplasie Typ 2 (MEN2)
- Familiärer medullärer Schilddrüsenkrebs
- PTEN-Hamartom-Tumor-Syndrom
- Retinoblastom
- Hereditäres Paragangliom-Pheochromozytom-Syndrom (PGL/PCC)
- Tuberöse Sklerose-Komplex (TSC)
- WT1-verwandter Wilms-Tumor
- Neurofibromatose Typ 2 (NF2)
- Juveniles Polyposis-Syndrom (JPS)
- Marfan-Syndrom
- Loeys-Dietz-Syndrom (LDS)
- Thorakale Aortenaneurysmen und/oder Dissektionen (TAAD)
- Ehlers-Danlos-Syndrom, vaskulärer Typ
- Hypertrophe Kardiomyopathie
- Dilatierte Kardiomyopathie
- Katecholaminerge polymorphe ventrikuläre Tachykardie (CPVT)
- Arrhythmogene rechtsventrikuläre Kardiomyopathie (ARVC)
- Romano-Ward long-QT-Syndrom
- Brugada-Syndrom (BrS)
- Familiäre Hypercholesterinämie (FH)
- Wilson-Krankheit
- Anfälligkeit für maligne Hyperthermie (MHS)
- Ornithin-Transcarbamylase-Mangel (OTC)
Simple workflow
*To generate this report, a sequencing test is mandatory. If you have not yet acquired a sequencing test, kindly make the purchase at this link: Dante Genome Test now!
Purchase your report adding your kit ID in the checkout notes.*
Get a Dante Genome Test
Access your Genome Manager account to view your new reports!
Genome Manager portal
You can purchase reports in the Genome Manager to skip step 1
Genome Manager portal
Additional Reports
Choose a report's category:
FAQs
How will my data be used?
Your data is yours. Which is why we have developed proprietary software linked to a dedicated platform, the Genome Manager, to provide you with unique access to your data whenever you want, wherever you are.
How can my doctor use the results?
You will be provided with a digital version of the raw data and reports. Thanks to these in-depth tools, you will be able to share your preferred information with your geneticist and/or doctor to indicate and plan the healthiest course for you.
How will I receive my reports?
The first thing to do when you receive your kit is to register it on your Genome Manager account. Dante's proprietary platform will keep you up-to-date on all stages of your genetic journey, providing you with the real-time status of your sample and where you can download your free report and raw data* at any time.
*Raw data will be available free of charge for the first 30 days after release.
How can I add other reports to my account?
At any time, you can log into your Genome Manager account and visit the Shop section. Here you will find a catalog with more than 150 additional reports dedicated to all areas of health. In addition, by subscribing to our newsletter you can always see new reports and panel updates.
Our certifications
